Regulatory compliance and quality are crucial for patient safety. To provide confidence in the effectiveness of our software, we follow strict quality guidelines throughout our organisation and our processes.
Having obtained CE-IVD certification for our rare disease as well as inherited and somatic cancer platforms, we can provide proof of compliance with European standards and regulations.
You can be confident that our software has been thoroughly validated as stated in our intended use statements, and trust us to continuously improve our products to ensure patient safety and product effectiveness.
Our Products and Services
Our products and services are consolidated on one single scalable, automated analysis and diagnostic platform that encompasses inherited disease, somatic cancer, pharma insights and pathogen surveillance. Our platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer and is uniquely placed to drive ubiquitous use of complex data in routine clinical care.
Our quality assurance
